Cellectar biosciences to report first quarter financial results and host a conference call on tuesday, may 13, 2025

Florham park, n.j., may 07, 2025 (globe newswire) -- cellectar biosciences, inc. (nasdaq: clrb), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced that the company will report financial results for the first quarter ended march 31, 2025, and provide a corporate update on may 13, 2025, at 8:30 a.m. eastern time.
CLRB Ratings Summary
CLRB Quant Ranking